Home Biosimilar Antibodies Others Others null Mirvetuximab-MMAE For research use only.
Not for use in humans.

Mirvetuximab-MMAE

Mirvetuximab-MMAE is an ADC targeting FOLR1 (folate receptor 1). It can be used in ovarian and other FRα-positive cancer research. MW :145.96 KD.

Mirvetuximab-MMAE

CAS No.

Purity & Quality Control

Batch: D406001 Purity: 99% Protein concentration: 10.91mg/ml Endotoxin Level: ＜1EU/mg
99

Biological Activity

Description Mirvetuximab-MMAE is an ADC targeting FOLR1 (folate receptor 1). It can be used in ovarian and other FRα-positive cancer research. MW :145.96 KD.

Product Details

Molecular Weight 145.96
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Mirvetuximab-MMAE | Mirvetuximab-MMAE supplier | purchase Mirvetuximab-MMAE | Mirvetuximab-MMAE cost | Mirvetuximab-MMAE manufacturer | order Mirvetuximab-MMAE | Mirvetuximab-MMAE distributor